Exobiosphere
Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.
About
Exobiosphere is a Luxembourg-based biotechnology company that is pioneering high-throughput drug discovery in microgravity. They are building the Orbital High-Throughput Screener (OHTS), an autonomous, standardized lab automation platform designed for space, enabling pharmaceutical and biotech partners to run automated experiments in orbit at scale. The company aims to accelerate drug discovery and unlock therapies that are difficult or impossible to develop on Earth by leveraging the unique conditions of microgravity. Teams look it up for Biotechnology, Space, Biotech.
Frequently asked
What does Exobiosphere do?
Exobiosphere is a Biotechnology company that offers Platform. Teams look it up for Space, Biotech, SpaceTech. It is based in Esch-sur-Alzette, Luxembourg and was founded in 2024. Public records show about 27 people and $3M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Exobiosphere raised?
Exobiosphere has raised a total of $3M in funding. The most recent round on record is Grant.
Where is Exobiosphere headquartered?
Exobiosphere is headquartered in Esch-sur-Alzette, Luxembourg.
When was Exobiosphere founded?
Exobiosphere was founded in 2024.
What industry does Exobiosphere operate in?
Exobiosphere operates in Biotechnology, Space, Biotech, SpaceTech, Drug Discovery.
How many employees does Exobiosphere have?
Exobiosphere has approximately 27 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.